Governor fetes police personnel at TOI event
The event was held at GL Bajaj Educational Institutions in Greater Noida on Monday.
Tired of too many ads? go ad free now
Governor an chief guest Anandiben Patel felicitated 17 police officers and employees who excelled in 15 categories of police operations. Additionally, she encouraged an NCC cadet by presenting a memento.
In her address, Patel urged students, teachers, and administrative officials to play an active role in education, innovation, and women's empowerment.
"The purpose of education should not just be to obtain a degree but to foster overall development and create sensitive citizens", the governor said.
She said the modern policing system of Uttar Pradesh has strengthened the law and order situation in the state.
"Earlier, industrialists faced difficulties in establishing their industries in the state due to security and other reasons. However, the situation has now reversed, and Uttar Pradesh's law and order has become exemplary," the governor said. Anandiben Patel also shared her thoughts on traffic awareness, suggesting that a campaign be run to enforce traffic rules in the district to reduce the number of accidents.
Gautam Budh Nagar member of Parliament Mahesh Sharma said police personnel provide us with security by working day and night, and should be respected.
Police commissioner Lakshmi Singh shared insights on modern policing using advanced technology. She said Gautam Budh Nagar police commissionerate is the first in Uttar Pradesh to have its police stations ISO certified.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
26 minutes ago
- Mint
Donald Trump threatens to use import restrictions on foreign drugmakers to reduce prices — Does it affect India?
US President Donald Trump on Tuesday threatened to use import restrictions to force foreign suppliers to reduce drug prices. Speaking at the White House at an event with Republican lawmakers, Trump further warned pharma companies to face a 'lot of problems' if they do not agree to reduce the drug prices in the US. Trump pledged to reduce what consumers must pay for prescription drugs. 'Drug companies will have lot of problems if they don't agree to bring prices down,' he said, making hinting at plans to use trade policy as leverage. 'We are going to get drug prices down… We will use import restrictions to force foreign suppliers to cut drug prices.' The US President's statement comes more than a month after he signed a broad executive order in June directing drugmakers to lower the prices of their prescription drugs to align with what other countries pay. The order said the Trump administration will give drugmakers price targets within a month and, if they fail to make "significant progress", may pursue regulatory actions or measures like importing medicines -- though analysts and legal experts say such steps would be difficult to implement. India plays a key role in supplying pharmaceutical products to the US, including generic drugs and active pharmaceutical ingredients (APIs). According to a report by The Times of India, New Delhi supplies around 35 per cent of all generic drugs prescribed in the US. Therefore, Trump's order to force foreign drugmakers to cut drug prices using import restrictions could significantly affect them, coupled with the fact that India and US have not signed a trade deal as yet. However, in June, Crisil Ratings had said Donald Trump's executive order on reducing prescription drug prices will have a limited impact on Indian pharma companies. Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of its pharmaceutical output, the bulk comprises low-priced generic drugs, which already operate on razor-thin margins, leaving little room for further price cuts to materially affect revenues. "API exports (15 per cent of India's pharma exports) are expected to be broadly unaffected, as it is not a major cost for high-margin originator drugs, abating concerns of pricing pressure," the report said. Generic pharma drugs account for 90 per cent of the prescription sales volume but only 13 per cent of the value spending in the US. Generic drug prices in the US are very low and have lower prices in comparison to economically peer countries, it said.
Time of India
12 hours ago
- Time of India
Mehsana, Rajkot dairy heads elected GCMMF chairman, vice-chairman
Vadodara: There is a change of guard at the Anand-headquartered Gujarat Cooperative Milk Marketing Federation (GCMMF), the world's largest farmer-owned dairy cooperative, after five years. The GCMMF board, popularly called Amul Federation, on Tuesday elected Mehsana Dairy chairman Ashok Chaudhary and Rajkot Dairy chairman Gordhan Dhameliya as chairman and vice-chairman of GCMMF. The duo replace Sabar Dairy chairman Shamal Patel and Sarhad Dairy chairman Valamji Humbal at the GCMMF top posts. Patel and Humbal served two terms of two and a half years each after being elected in 2020. Patel was on a sticky wicket after protests by dairy farmers at Himmatnagar, which also took a violent turn as protesters clashed with police. The election on Tuesday saw the participation of all 18 member unions of GCMMF that market dairy products under the brand name 'Amul'. Chaudhary and Dhameliya were elected unopposed based on the mandate from the BJP leadership. Chaudhary's name was proposed by Patel, the outgoing chairman, and seconded by Ashwin Salawiya, chairman of Amreli Dairy. Dhameliya's name was proposed by Humbal and supported by Mohan Bharwad, chairman of Ahmedabad Milk Union. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Special Offer On Exclusive Watches Luxury Watches Shop Now Undo The election was conducted in the presence of the Anand district collector and the registrar of cooperatives of the Gujarat govt. After being appointed chairman, Chaudhary thanked Prime Minister Narendra Modi for positioning Amul as a global dairy brand. He also thanked Union home and cooperation minister Amit Shah, Gujarat chief minister Bhupendra Patel, state BJP chief C R Paatil, and minister of cooperation in the Gujarat govt Jagdish Vishwakarma. After its inception in 1973, GCMMF was headed by its founder chairman, the late Dr Verghese Kurien, who stepped down in 2006. He was the last non-political chairman of the federation. From 2006, GCMMF chairmanship has been held by Banaskantha's Banas Dairy (Parthi Bhatol), Mehsana's Dudhsagar Dairy (earlier Vipul Chaudhary and now Ashok Chaudhary), Sabarkantha's Sabar Dairy (earlier Jetha Patel and later Shamal Patel), and Anand's Amul Dairy (Ramsinh Parmar). Banas, Mehsana, Sabar and Amul are the four biggest milk unions of Gujarat. The post of vice-chairman, which was created in 2015 through an amendment in GCMMF bylaws, was first held by Panchmahals-based Panchamrut Dairy's chief Jetha Bharwad, later by Humbal, and now by Dhameliya. In the 2024-25 financial year, GCMMF recorded a turnover of Rs 65,911 crore ($7.7 billion). During this period, the federation procured more than 12 billion litres of milk and achieved a brand turnover of Rs 90,000 crore ($11 billion) through its member unions.
News18
18 hours ago
- News18
PLI scheme for bulk drugs led to import savings of Rs 1,362 cr: Govt
New Delhi, Jul 22 (PTI) Imports of pharma raw materials worth Rs 1,362 crore have been avoided till March 2025 due to the creation of domestic manufacturing capacity for 25 identified items under the production-linked incentive scheme for bulk drugs, Parliament was informed on Tuesday. In a written reply to Rajya Sabha, Minister of State for Chemicals and Fertilisers, Anupriya Patel said that as of March 2025, against an investment commitment of Rs 3,938.5 crore over the period of six years, investment of Rs 4,570 crore has already been made under the PLI Scheme for Bulk Drugs. 'As a result of the scheme, cumulative sales of Rs 1,817 crore have been reported over the period from the beginning of the scheme till March 2025, including exports of Rs 455 crore, thereby avoiding imports worth Rs 1,362 crore and creation of domestic manufacturing capacity for 25 identified KSMs/DIs/APIs," she stated. The PLI Scheme for Bulk Drugs has a total budgetary outlay of Rs 6,940 crore and aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs for which there are no alternatives by reducing supply disruption risk due to excessive dependence on a single source, the minister said. Products notified and approved under the scheme prior to commencement of production under the PLI scheme were primarily imported. The government has also initiated a PLI Scheme for Pharmaceuticals with a total budgetary outlay of Rs 15,000 crore. Under the scheme for promotion of bulk drugs parks, which has a total budgetary outlay of Rs 3,000 crore, three parks have been approved and are at various stages of development in Andhra Pradesh, Gujarat and Himachal Pradesh, Patel said. PTI MSS MSS SHW view comments First Published: July 22, 2025, 17:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
